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Abstract
We used contact tracing to document how COVID-19 was transmitted across 5 gen-
erations involving 10 cases, starting with an individual who became ill on January 27. 
We calculated the incubation period of the cases as the interval between infection 
and development of symptoms. The median incubation period was 6.0 days (inter-
quartile range, 3.5-9.5 days). The last two generations were infected in public places, 
3 and 4 days prior to the onset of illness in their infectors. Both had certain underly-
ing conditions and comorbidity. Further identification of how individuals transmit 
prior to being symptomatic will have important consequences.
K E Y W O R D S
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1  | INTRODUC TION
Novel coronavirus disease 2019 (COVID-19) was declared a pan-
demic on March 11, 2020.1 Transmission chains have been difficult 
to identify in routine investigations. Notable cases in Italy2 and 
the United States3 had no known source of infection. These cases 
have raised the concern that there is transmission of the novel 
coronavirus (SARS-CoV-2) in asymptomatic individuals (who never 
express symptoms) or in pre-symptomatic individuals (prior to any 
symptoms).
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Many public actions so far, including quarantine measures, body 
temperature measurement, and fever symptom surveillance, have 
prioritized identification of possible infected cases. However, these 
all depend on active expression of symptoms and are not able to iden-
tify asymptomatic transmission or pre-symptomatic transmission.4
Better understanding of transmission parameters, including the 
serial interval and incubation period, can also help determine the 
possible progression of the outbreak. The serial interval is defined 
as the interval between a primary case of COVID-19 developing 
symptoms and a secondary case developing symptoms, whereas the 
incubation period is the time lag between infection and the start of 
symptoms. The Chinese Center for Disease Control and Prevention 
(CDC) has estimated that the mean serial interval for COVID-19 is 
7.5 days, which is slightly longer than the estimated incubation pe-
riod of 5.2 days.5 However, the serial interval has varied in other 
studies, such as a median of 4.6 days,6 which is shorter than the in-
cubation period.
The challenge for controlling COVID-19 is to determine at what 
point an individual becomes infectious, which can have implications 
for contact tracing and other epidemiological investigations. In ad-
dition, one study in China showed that 12.1% of transmission was 
likely to be pre-symptomatic.7 On February 24, 2020, the China CDC 
revised the definition of the start date for close contact from “at 
the illness onset of a confirmed case” to “2 days before the illness 
onset,”8 as increased evidence suggests pre-symptomatic transmis-
sion might be plausible.
Many previous studies of the transmission dynamics of COVID-
19 have relied on publicly available data or large surveillance data-
sets. It is difficult to discover asymptomatic or pre-symptomatic 
cases in these datasets, and overall there is limited information on 
how to determine when an individual becomes infectious. This study 
describes a transmission chain of 5 generations involving 10 COVID-
19 cases, and tracks whether infection occurred from asymptomatic 
or pre-symptomatic individuals.
2  | METHODS
An index case (ie, the last case) was first identified in our study who 
had no obvious previous contact with a symptomatic case of COVID-
19. For the index case, we identified 3 close contacts in the 14 days 
prior to disease onset, none of which had COVID-19 at the time of 
contact. We worked backward to identify several generations of 
transmission. We used contact tracing to identify possible people 
who could have exposed the case. Close contacts were defined as 
people who live, study, work, or otherwise have close contact with 
the case; medical personnel, family members, or other people who 
have similarly had close contact with the case and who did not take 
effective protective measures; other patients and their accompany-
ing staff in the same ward of the case; persons in the same vehicle as 
the case and who had close contact with the case; and other persons 
who were deemed close contacts by the field investigator.
We retrospectively summarized the journey and visited places 
of the cases within 14 days before the illness onset in each gen-
eration. In this way, we identified possible source cases and we 
worked backward to identify cases, which were epidemiologically 
linked with each other, and which constituted a complete trans-
mission chain. Information about symptoms and date of illness 
onset was provided directly by the cases. We acknowledge recall 
bias: Cases may not have been able to remember every contact 
they had.
All of the investigations were conducted by experienced investi-
gators at Centers for Disease Control and Prevention in the Shanghai 
Municipality and Zhejiang Province. This study involved the use of 
existing, routinely collected data from a public health outbreak in-
vestigation, under the National Health Commission of the People's 
Republic of China. Thus, this study is exempt from ethical review and 
informed consent was not obtained.
3  | RESULTS
3.1 | Initiation of investigation
The index case was a 74-year-old female who developed symptoms 
on January 27. She lived alone and had very limited contact with 
foreign people. She was found to have met with a 75-year-old male, 
in a real estate trade center for 3 hours on January 21, 6 days prior 
to the onset of her symptoms. The male was recognized as an exist-
ing confirmed case (case 1) of COVID-19, who developed symptoms 
only on January 25. Subsequently, case 2 was identified, who was a 
friend of case 1 and had met him for 2.5 hours at a gym on January 
19. Case 2 developed symptoms on January 22. The timeline of pos-
sible infection and illness onset is illustrated in Figure 1.
3.2 | Identification of two occasions of pre-
symptomatic transmission
We determined the epidemiological linkages between index case, 
case 1, and case 2, after excluding all of their close contacts who re-
mained healthy throughout a 14-day medical observation. It is noted 
that the infectees (index case and case 1) were possibly infected 
with SARS-CoV-2 by infectors (case 1 and case 2) during the incuba-
tion periods of the infectors (Figure 1).
To confirm the finding, we further checked whether there was 
previous contact between these cases. Cases 1 and 2 had not met 
for about one month, and did not meet after January 19. Thus, 
the transmission was likely to occur on January 19 in the gym. 
The index case and case 1 had also met on January 18. However, 
case 1 was not infected on that day and thus was likely to have 
occurred on January 21. Through an examination of cases 1 and 
2's clinical symptoms, we inferred both transmitted infection while 
pre-symptomatic.
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3.3 | Source of transmission chain
We worked backward to further investigate the chain of transmis-
sion. Case 2 and case 3 had not met before; however, they possibly 
became infected by a common friend (case 4) at dinners on January 
13 and 14. Similarly, cases 4-7 became infected at dinners with a 
common friend (case 8). During the dinners, case 8's daughter (case 
9) could have been the common source of infection, and she was 
infected by her co-worker who had traveled back from the city of 
Wuhan, Hubei Province. Across these cases, we did not recognize 
any evidence of pre-symptomatic transmission.
3.4 | Incubation period and serial interval
In this study, all the cases had an incubation period less than 
14 days, with a median of 6.0 days (interquartile range, 3.5-9.5 days). 
Comparatively, we calculated the median serial interval to be 
5.0 days (interquartile range, 3.0-5.0 days). For the two instances of 
pre-symptomatic transmission, the infectees' contact with the infec-
tors occurred 3 or 4 days prior to the infectors' illness onset, which 
suggests a shorter latent period than an incubation period.
3.5 | Co-morbidities
To identify differences between pre-symptomatic transmission and 
symptomatic transmission, we examined the health conditions of 
all cases. The index case underwent a surgery for stomach cancer 
and had been receiving chemotherapy for 1.5 years. Case 1 suffered 
from pneumonia and recovered late December 2019. No other cases 
had underlying conditions and comorbidity.
4  | DISCUSSION
In this study, we traced the spread of coronavirus across five genera-
tions in Shanghai, China, back to a case who had previously traveled 
to Wuhan, the original source of the outbreak. The serial interval 
was estimated to be a little shorter than the incubation period, and 
there were no known symptoms among suggested possible pre-
symptomatic transmission. However, two infector-infectee pairs 
with pre-symptomatic transmission were identified out of 9 pairs. 
The index case and case 1 may have been more susceptible to pre-
symptomatic infection due to their health conditions, compared to 
other cases.
F I G U R E  1   Time line of contact and illness onset of novel coronavirus disease 2019 (COVID-19) cases in late January 2020. The persons 
involved in transmission venues are listed, including four dinners (on January 9 and 10, January 13 and 14) and two meetings in public places 
(on January 19 and 21). Not shown are additional close contacts (with individuals who remained symptom-free after a 14-day quarantine): 3 
for the index case, 1 for case 1, 1 for case 2, 11 for case 3, 12 for case 5, 1 for case 8, and 1 for case 9
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That the latent period may be shorter than the incubation pe-
riod could affect recommendations for contact tracing and case 
definitions. We found evidence of pre-symptomatic transmission 
3-4 days prior to the infectors' illness onset. Thus, we suggest ad-
vancing the upper time limit of close contact to 4 days prior to 
illness onset of a COVID-19 case, which is greater than the China 
CDC and WHO guidelines of 2 days.8,9 We note that guidelines 
in Beijing use a time limit of 4 days as of May 18, 2020.10 One 
another study in China reported only 2-day lead time between 
infectee's contact with the infector and infector's illness onset,11 
and we have not found any information that this could be longer. 
We recognize that increasing the duration of a possible time of 
infection can add to the workload of routine epidemiological in-
vestigations during the epidemic of COVID-19. Consequently, we 
recommend it should be applied to cases with an unknown source 
of infection, such as the index case in our study. Contact tracing 
guidelines should also rely on the capacity of contact tracing and 
on updated information on when pre-symptomatic transmission 
can occur. For example, a study of COVID-19 cases in Taiwan also 
started investigations of COVID-19 up to 4 days before symptom 
onset, although this was not consistently done.12 Evidence from 
more chains of transmission can better delineate the borderline 
between the latent period and infectious period.
Asymptomatic transmission has been documented among re-
turned Japanese citizens from China.13 However, it might be mis-
understood due to short duration of observation, that is to say, if 
we extend the duration of observation, we might observe the oc-
currence of symptoms. Consequently, pre-symptomatic transmis-
sion may be misunderstood as asymptomatic transmission. So far, 
asymptomatic transmission and pre-symptomatic transmission have 
not been well documented and further study of natural history of 
SARS-CoV-2 infection is urgently warranted.
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